Swiss National Bank’s Acutus Medical Inc AFIB Stock Holding History

Swiss National Bank’s Portfolio AFIB Stock Details AFIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-18,900	Closed	-$253K	–	2654
2021 Q1	$253K	Hold	18,900	–	–	﹤0.01%	2478
2020 Q4	$545K	Buy	+18,900	New	+$512K	﹤0.01%	2449

Other funds holding AFIB

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Kerrisdale Advisers Miami, Florida $399M AUM 42.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Jetstream Capital Brentwood, Tennessee $1.37M AUM

Swiss National Bank's AFIB Position: Q2 2021 in Review

Swiss National Bank sold out of Acutus Medical Inc (AFIB) in Q2 2021, closing a stake of 18,900 shares — an estimated $253K sold.

Swiss National Bank first reported a position in AFIB in Q4 2020 and held it in 2 quarters. The position peaked at $545K in Q4 2020. 64 funds tracked by Wall St. Rank hold AFIB as of Q2 2021.

Swiss National Bank reported no remaining Acutus Medical Inc position as of Q2 2021 after selling out during the quarter.
Swiss National Bank sold 18,900 Acutus Medical Inc shares in Q2 2021, an estimated $253K.
Swiss National Bank first reported a position in Acutus Medical Inc in Q4 2020 and held it in 2 quarters.
Swiss National Bank's Acutus Medical Inc position peaked at $545K in Q4 2020.
64 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2021.

Based on Swiss National Bank's 13F filing for Q2 2021, filed 6 Aug 2021.